These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 19100463

  • 1. Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?
    Ju MK, Chang HK, Kim HJ, Huh KH, Ahn HJ, Kim MS, Kim SI, Kim YS.
    Transplant Proc; 2008 Dec; 40(10):3673-8. PubMed ID: 19100463
    [Abstract] [Full Text] [Related]

  • 2. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
    Akbas SH, Ozdem S, Caglar S, Tuncer M, Gurkan A, Yucetin L, Senol Y, Demirbas A, Gultekin M, Ersoy FF, Akaydin M.
    Clin Biochem; 2005 Jun; 38(6):552-7. PubMed ID: 15885236
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
    Bartlomiejczyk I, Zochowska D, Sanko-Resmer J, Matuszewicz D, Paczek L.
    Transplant Proc; 2006 Jun; 38(1):94-6. PubMed ID: 16504673
    [Abstract] [Full Text] [Related]

  • 4. Effect of the hematocrit and its correction on the relationship between blood tacrolimus concentrations obtained using the microparticle enzyme immunoassay (MEIA) and enzyme multiplied immunoassay technique (EMIT).
    Bouzas L, Ortega FJ, Casado P, Arranz MI, Carcas A, Tutor JC.
    Clin Lab; 2007 Jun; 53(9-12):591-6. PubMed ID: 18257466
    [Abstract] [Full Text] [Related]

  • 5. [Performance evaluation of affinity column mediated immunometric assay for tacrolimus].
    Chung JW, An D, Song J, Chung HJ, Park HI, Lee W, Chun S, Min WK.
    Korean J Lab Med; 2009 Oct; 29(5):415-22. PubMed ID: 19893350
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the affinity column-mediated immunoassay and microparticle enzyme immunoassay methods as a tacrolimus concentration assay in the early period after liver transplantation.
    Joo DJ, Jung I, Kim MS, Huh KH, Kim H, Choi JS, Choi GH, Kim SI.
    Transplant Proc; 2010 Dec; 42(10):4137-40. PubMed ID: 21168645
    [Abstract] [Full Text] [Related]

  • 7. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
    Tempestilli M, Di Stasio E, Basile MR, Elisei F, Antonini M, Ettorre GM, Iappelli M, Pucillo LP.
    Ther Drug Monit; 2013 Feb; 35(1):96-100. PubMed ID: 23191996
    [Abstract] [Full Text] [Related]

  • 8. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
    Ventura E, Bonardet A, Pageaux GP, Mourad G, Cristol JP.
    Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
    [Abstract] [Full Text] [Related]

  • 9. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS, Taylor PJ, Salm P, Morris RG.
    Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
    [Abstract] [Full Text] [Related]

  • 10. Comparison of blood tacrolimus concentrations in liver and kidney transplant recipients using ACMIA and MEIA immunoassays.
    Freire A, Hermida J, Tutor JC.
    Ups J Med Sci; 2008 Oct; 113(1):103-10. PubMed ID: 18521804
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients.
    Akbas SH, Yavuz A, Tuncer M, Yurdakonar E, Akcit F, Gurkan A, Demirbas A, Gultekin M, Ersoy F, Akaydin M.
    Transplant Proc; 2004 Oct; 36(1):86-8. PubMed ID: 15013308
    [Abstract] [Full Text] [Related]

  • 12. Preliminary evaluation of the new TACR flex method versus MEIA method in the therapeutic monitoring of tacrolimus in organ transplantation.
    Bachetoni A, Mariani P, D'Alessandro M, Baiano V, Appodia C, Collepardo D, Berloco P.
    Transplant Proc; 2007 Oct; 39(6):2008-9. PubMed ID: 17692678
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
    Bazin C, Guinedor A, Barau C, Gozalo C, Grimbert P, Duvoux C, Furlan V, Massias L, Hulin A.
    J Pharm Biomed Anal; 2010 Dec 01; 53(4):997-1002. PubMed ID: 20674215
    [Abstract] [Full Text] [Related]

  • 14. Difference in blood tacrolimus concentration between ACMIA and MEIA in samples with low haematocrit values.
    Doki K, Homma M, Hori T, Tomita T, Hasegawa Y, Ito S, Fukunaga K, Kaneko M, Chiba S, Sumida T, Ohkohchi N, Kohda Y.
    J Pharm Pharmacol; 2010 Sep 01; 62(9):1185-8. PubMed ID: 20796198
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of hematocrit interference in the tacrolimus II microparticle enzyme immunoassay: a tentative approach.
    Hermida J, Fernández MC, Tutor JC.
    Clin Lab; 2005 Sep 01; 51(1-2):43-5. PubMed ID: 15719703
    [Abstract] [Full Text] [Related]

  • 16. More on the reliability of the microparticle enzyme immunoassay (MEIA) for therapeutic tacrolimus monitoring.
    Hermida J, Tutor JC.
    Clin Lab; 2003 Sep 01; 49(9-10):471-4. PubMed ID: 14572203
    [Abstract] [Full Text] [Related]

  • 17. Clinical outcomes of renal transplantation using liquid chromatographic monitoring of tacrolimus.
    Borrows R, Chusney G, Loucaidou M, James A, Stichbury J, Van Tromp J, Cairns T, Griffith M, Hakim N, McLean A, Palmer A, Papalois V, Taube D.
    Ther Drug Monit; 2006 Apr 01; 28(2):269-73. PubMed ID: 16628143
    [Abstract] [Full Text] [Related]

  • 18. Falsely abnormally elevated blood trough concentration of tacrolimus measured by antibody-conjugated magnetic immunoassay in a renal transplant recipient: a case report.
    Toraishi T, Takeuchi H, Nakamura Y, Konno O, Yokoyama T, Iwamoto H, Hama K, Hirano T, Unezaki S, Okuyama K, Shimazu M.
    Transplant Proc; 2012 Jan 01; 44(1):134-6. PubMed ID: 22310597
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of a new immunoassay for therapeutic drug monitoring of tacrolimus in adult liver transplant recipients.
    Marubashi S, Nagano H, Kobayashi S, Eguchi H, Takeda Y, Tanemura M, Umeshita K, Monden M, Doki Y, Mori M.
    J Clin Pharmacol; 2010 Jun 01; 50(6):705-9. PubMed ID: 20097937
    [Abstract] [Full Text] [Related]

  • 20. Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanese liver transplant recipients.
    Hashi S, Masuda S, Kikuchi M, Uesugi M, Yano I, Omura T, Yonezawa A, Fujimoto Y, Ogawa K, Kaido T, Uemoto S, Matsubara K.
    Transplant Proc; 2014 Apr 01; 46(3):758-60. PubMed ID: 24767342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.